Google
NDRA — ENDRA LIFE SCIENCES INC (Healthcare >> Diagnostics & Research)
NDRA FAQ
What is NDRA's ROE?
ENDRA LIFE SCIENCES INC reports a Return on Equity (ROE) of -408.67%.
What is NDRA's dividend yield?
ENDRA LIFE SCIENCES INC offers a dividend yield of 0.00%.
What is NDRA's Deepscope Quality Score?
Deepscope rates NDRA's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NDRA?
Deepscope's AI Timing Score for NDRA is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NDRA belong to?
ENDRA LIFE SCIENCES INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 4.77
Price
0.04
(0.85%)
Day Change
|
|
|---|
NDRA, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.77 |
| PBV / Sector |
5.03 / -24.29
|
| Earning Per Share | -3.87 |
| PE / Sector |
N/A / 37.70
|
| PEG or PE/Growth / Sector |
N/A / 1.35
|
| Average 1M Daily Value |
0.10 M
GREAT
|
| Average 1W Daily Value |
0.07 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:11:54 |
| Symbol | NDRA |
| Name | ENDRA LIFE SCIENCES INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 1.85 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 8.99 / 31,702.25 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3600 Green Court, Ann Arbor, MI, United States, 48105-1570
Phone: 734 335 0468
Website: https://endrainc.com
Description: ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
